WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gyre Therapeutics earnings were $12.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GYRE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$99.0k, down 108.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GYRE reported annual earnings of $12.1M, with -113% growth. The next GYRE earnings date is Jun 12, 2025.

GYRE past earnings growth

How has GYRE's earnings growth performed historically?

Company
N/A
Industry
11.24%
Market
33%
GYRE's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GYRE's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

GYRE earnings history

Current Revenue
$105.8M
Current Earnings
$12.1M
Current Profit Margin
11.4%

GYRE Return on Equity

Current Company
19.9%
Current Industry
-2%
Current Market
34.1%
GYRE's Return on Equity (19.9%)... subscribe to Premium to read more.
High Return on Equity Performance

GYRE undefined

Current Company
9.8%
Current Industry
-0.4%
GYRE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GYRE announces earnings.

GYRE undefined

Current Company
16.44%
Current Industry
5.9%
GYRE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GYRE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GYRE$19.63M$12.09M+87.08%$0.14
RCUS-$369.00M-$391.00MN/A-$4.19
ARDX-$31.70M-$53.76MN/A-$0.22
ELVN-$88.16M-$89.02MN/A-$1.89
NTLA-$508.74M-$519.02MN/A-$5.25
View Top Biotech Stocks

GYRE earnings dates

Next earnings date
Jun 12, 2025

Gyre Therapeutics Earnings Reports & History FAQ

What were Gyre Therapeutics's earnings last quarter?

On GYRE's earnings call on Invalid Date, Gyre Therapeutics (NASDAQ: GYRE) reported Q4 2024 earnings per share (EPS) of $0.00, up 100% year over year. Total GYRE earnings for the quarter were -$99.00 thousand. In the same quarter last year, Gyre Therapeutics's earnings per share (EPS) was -$1.54.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

When does Gyre Therapeutics report earnings?

The next GYRE earnings date is Invalid Date. Add GYRE to your watchlist to be reminded of Gyre Therapeutics's next earnings date.

What was GYRE's earnings growth in the past year?

As of Gyre Therapeutics's earnings date in Invalid Date, Gyre Therapeutics's earnings has grown year over year. GYRE earnings in the past year totalled $12.09 million.

Is Gyre Therapeutics profitable or losing money?

As of the last Gyre Therapeutics earnings report, Gyre Therapeutics is currently profitable. Gyre Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $12.09 million, a 113% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.